Abstract:Objective To explore the expression of NANOG gene in acute lymphoblastic leukemia (ALL) cell lines and the effect of down-regulation of NANOG on the proliferation and cell cycle of ALL cells.Methods Three kinds of ALL cell line MOLT-4,CCRF-HSB2 and Jurkat were chosen as study object.The expression of NANOG was detected by reverse transcription-polymerase chain reaction (RTPCR) and Western blot in MOLT-4,CCRF-HSB2 and Jurkat cells.The lentiviral vector (pLB-shNANOG-1 and pLB-shNANOG-2) carrying NANOG specific shRNA were constructed.After infection of MOLT-4 cells with the lentivirus constructs,green fluorescent protein positive cells were harvested by flow cytometry as interference group.With empty plasmid (pLB-sh control) infected MOLT-4 cells and normal cells were used as wild-type group and control group.The efficiency of RNA interference was detected by real-time quantitative PCR and Western blot.Cell proliferation was evaluated using CCK-8 cell counting kit.Cell cycle was analyzed by flow cytometry.The expression of p53-related gene was detected by real-time quantitative PCR.Results The virus titers were (1.83-3.12)×108 IU/mL.Each interfering sequence cloud stably down-regulate the expression of NANOG.Analysis of cell proliferation indicated that the MOLT-4 cells expressing NANOG shRNA grew significantly slower than wild-type cells and control cells,and this difference became more obvious after 72 hours (P＜0.001).Cell cycle analysis indicated that the percentage of S-phase cells in wild-type or control group cells was obviously increased when compared to MOLT-4 cells expressing NANOG shRNAs (P＜0.01).The percentage of MOLT-4 cells expressing NANOG shRNAs in the G0/G1-phase was higher than in wild-type cells and control cells (P＜0.001),while the percentage of cells in the G2/M-phase was not statistical different among these cells (P＞0.05).The expression of gene TP53 and CDKN1A were increased in groups of shNANOG-1 and shNANOG-2 than that of groups of control and wild-type (P＜0.05).But the expression of gene MDM2 and CCND1 was decreased (P＜0.05).Conclusions NANOG is expressed in some human ALL cell lines.Down-regulation of NANOG could inhibit cell proliferation and arrest in the cell cycle of G0/G1 phase through a MDM2-TP53 CDKN1A pathway in leukemic cells.

RNA interference-mediated silencing of NANOG leads to reduced proliferation and self-renewal, cell cycle arrest and apoptosis in T-cell acute lymphoblastic leukemia cells via the p53 signaling pathway

Effects of NANOG Expression on Proliferation and Cell Cycle of Acute Lymphoblastic Leukemia Cells

[Effects of NANOG Gene Down-Regulation on the Apoptosis of T-cell Acute Lymphoblastic Leukemia Cells].

Expression of NANOG Gene in Acute Lymphoblastic Leukemia Cells and Construction of Lentiviral Vector Carrying NANOG Specific shRNA

Linalool Inhibits the Growth of Human T Cell Acute Lymphoblastic Leukemia Cells with Involvement of the MAPK Signaling Pathway

The IGF2/IGF1R/Nanog Signaling Pathway Regulates the Proliferation of Acute Myeloid Leukemia Stem Cells

Nanog regulates molecules involved in stemness and cell cycle-signaling pathway for maintenance of pluripotency of P19 embryonal carcinoma stem cells

Regulation of NANOG in cancer cells

LncRNA PPM1A-AS Regulate Tumor Development Through Multiple Signal Pathways in T-Cell Acute Lymphoblastic Leukemia

Functional evidence that the self-renewal gene NANOG regulates esophageal squamous cancer development

YBX1 as an oncogenic factor in T-cell acute lymphoblastic leukemia

RNAi mediated silencing of Nanog expression suppresses the growth of human colorectal cancer stem cells

NANOG Promotes Cell Proliferation, Invasion, and Stemness via IL-6/STAT3 Signaling in Esophageal Squamous Carcinoma

The BET inhibitor GNE-987 effectively induces anti-cancer effects in T-cell acute lymphoblastic leukemia by targeting enhancer regulated genes

TALEN-mediated Nanog Disruption Results in Less Invasiveness, More Chemosensitivity and Reversal of EMT in Hela Cells

The NEDD8-activating enzyme inhibitor MLN4924 induces G2 arrest and apoptosis in T-cell acute lymphoblastic leukemia.

NANOG Promotes Liver Cancer Cell Invasion by Inducing Epithelial–mesenchymal Transition Through NODAL/SMAD3 Signaling Pathway

Genome-wide analyses identify KLF4 as an important negative regulator in T-cell acute lymphoblastic leukemia through directly inhibiting T-cell associated genes

Anti-tumor activity of niclosamide-mediated oxidative stress against acute lymphoblastic leukemia

NANOGP8 is a retrogene expressed in cancers.

Pluripotency Factor Nanog is Tumorigenic by Deregulating DNA Damage Response in Somatic Cells